Clinical Trials · NCT00667758
Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Betanien Hospital
- Enrollment
- 104
- Start date
- May 2008
- Locations
- 1 site, Norway
- Primary endpoint
- Change in Disease Activity Score (DAS28CRP) in cetrorelix group versus placebo group